PP
FOLD

Paloma Partners’s Amicus Therapeutics FOLD Stock Holding History

Paloma Partners’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-10,200
Closed -$98K – 1364
2021
Q2 		$98K Buy
+10,200
New +$99.6K ﹤0.01% 1652
2020
Q4 		– Sell
-140,133
Closed -$1.98M – 1827
2020
Q3 		$1.98M Buy
+140,133
New +$2.04M 0.05% 392
2020
Q1 		– Sell
-67,680
Closed -$659K – 1512
2019
Q4 		$659K Buy
+67,680
New +$620K 0.01% 1214
2017
Q1 		– Sell
-13,100
Closed -$65K – 2045
2016
Q4 		$65K Buy
+13,100
New +$90.7K ﹤0.01% 1921
2016
Q2 		– Sell
-18,001
Closed -$152K – 2203
2016
Q1 		$152K Sell
18,001
-20,095
-53% -$142K ﹤0.01% 1732
2015
Q4 		$370K Buy
+38,096
New +$343K 0.01% 1217
2015
Q3 		– Sell
-22,154
Closed -$313K – 1704
2015
Q2 		$313K Buy
22,154
+10,503
+90% +$126K 0.01% 1311
2015
Q1 		$127K Sell
11,651
-7,279
-38% -$64.2K ﹤0.01% 1112
2014
Q4 		$157K Buy
18,930
+1,872
+11% +$12.8K 0.01% 1037
2014
Q3 		$101K Sell
17,058
-113,190
-87% -$593K ﹤0.01% 893
2014
Q2 		$435K Buy
+130,248
New +$306K 0.02% 642

Other funds holding FOLD

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Paloma Partners's FOLD Position: Q3 2021 in Review

Paloma Partners sold out of Amicus Therapeutics (FOLD) in Q3 2021, closing a stake of 10,200 shares — an estimated $98K sold.

Paloma Partners first reported a position in FOLD in Q2 2014 and held it in 11 quarters. The position peaked at $1.98M in Q3 2020. 236 funds tracked by Wall St. Rank hold FOLD as of Q3 2021.

  • Paloma Partners reported no remaining Amicus Therapeutics position as of Q3 2021 after selling out during the quarter.
  • Paloma Partners sold 10,200 Amicus Therapeutics shares in Q3 2021, an estimated $98K.
  • Paloma Partners first reported a position in Amicus Therapeutics in Q2 2014 and held it in 11 quarters.
  • Paloma Partners's Amicus Therapeutics position peaked at $1.98M in Q3 2020.
  • 236 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q3 2021.

Based on Paloma Partners's 13F filing for Q3 2021, filed 15 Nov 2021.